Library
PubMed
research article
Professional

Steroid-Modified Dermatophytosis: A Clinical and Diagnostic Challenge.

Source: PubMed, NCBI / U.S. National Library of Medicine

CureusJadhav Vaishnavi, Mane Priyanka M, Patil Satish RPublished 5/1/2026Last synced 6/26/2026Status: syncedPMID: 42311730DOI: 10.7759/cureus.108993

Dermatophytosis represents one of the most prevalent superficial fungal infections affecting the skin, hair, and nails worldwide. In recent years, the widespread and often indiscriminate use of topical corticosteroids has been frequently combined with antifungal and antibacterial agents. This narrative review explores the impact of corticosteroid misuse on dermatophytosis, focusing on changes in pathogenesis, clinical manifestations, diagnostic challenges, management, and treatment. Special emphasis is placed on the emerging epidemic of steroid-modified dermatophytosis in India, driven by over-the-counter drug availability and irrational prescribing practices, leading to chronic, recurrent, and recalcitrant cases. Understanding these effects is essential for microbiologists and clinicians to enhance antifungal stewardship, treatment outcomes, and diagnostic precision.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.